Announcing our second fund
Paloma announces a second fund it is opening, seeking A$25 million to back studio-built GenAI ventures and breakout portfolio companies across Australia and New Zealand; no close is reported.
Investor · 1 deal
Every published round Paloma Capital took part in, and every parcel of existing shares it bought off another holder. Deals we hold but haven't published yet are not counted.
| Company | Stage | Announced | Amount | Role | Alongside | Sources |
|---|---|---|---|---|---|---|
| Marmalade | Unnamed stage | 19 Mar 2024 | $16m | Participant | SmartCompany (24 Jul 2024), SmartCompany (22 Mar 2024), Startup Daily, Australian FinTech, SmartCompany (19 Mar 2024) |
Companies Paloma Capital has backed in a published round, and companies whose existing shares it bought off another holder.
| Company | What it does | First invested | Rounds | Led |
|---|---|---|---|---|
| Marmalade | 19 Mar 2024 | 1 | 0 |
Fund closes reported for Paloma Capital, as distinct from the investments it has made.
Companies Paloma Capital has backed that another company then bought. An exit for the holding, not a deal Paloma Capital did.
| Name | Role | Sources |
|---|---|---|
| Ash Fogelberg | General Partner (former) | Startup Daily, Australian FinTech |
Stories naming Paloma Capital. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Paloma announces a second fund it is opening, seeking A$25 million to back studio-built GenAI ventures and breakout portfolio companies across Australia and New Zealand; no close is reported.
A weekly roundup detailing five raises across Australia and New Zealand: Marmalade, Cauldron, Prophet, Hola Health and Buddy, naming amounts, lead backers and founders.
SME invoicing startup Marmalade has banked $16 million in a round that Blue Stamp Company led, with existing backer Paloma Capital also taking part, taking lifetime capital past $32 million.
Also Australian FinTech·Startup Daily·SmartCompany·SmartCompany